NASDAQ: SCNI
Scinai Immunotherapeutics Ltd Stock Ownership - Who owns Scinai Immunotherapeutics?

Insider buying vs selling

Have Scinai Immunotherapeutics Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SCNI insiders and whales buy or sell their stock.

SCNI Shareholders

What type of owners hold Scinai Immunotherapeutics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
George Lowell0.01%421,680$864.44kInsider
Avner Rotman0.00%66,800$136.94kInsider
Morris C. Laster0.00%66,800$136.94kInsider
Yael Margolin0.00%66,800$136.94kInsider
Adi Raviv0.00%66,800$136.94kInsider
Ubs Group Ag0.00%23,488$48.15kInstitution
Rhumbline Advisers0.00%1,653$3.39kInstitution
Morgan Stanley0.00%255$522.75Institution
Credit Agricole S A0.00%42$86.10Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

SCNI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BDRX0.00%0.00%
SCNI0.00%0.02%
ONCO4.45%95.55%
VINC29.37%70.63%
GRI7.53%92.47%

Scinai Immunotherapeutics Stock Ownership FAQ

Who owns Scinai Immunotherapeutics?

Scinai Immunotherapeutics (NASDAQ: SCNI) is owned by 0.00% institutional shareholders, 0.02% Scinai Immunotherapeutics insiders, and 99.98% retail investors. George Lowell is the largest individual Scinai Immunotherapeutics shareholder, owning 421,680.00 shares representing 0.01% of the company. George Lowell's Scinai Immunotherapeutics shares are currently valued at $906.61k.

If you're new to stock investing, here's how to buy Scinai Immunotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.